Ambu: We had hoped to do it in our own time
A warning letter from the FDA to an Ambu-owned US company means the Danish company will now have to initiate processes they had hoped to carry out in their own time.
FDA asked for a time frame. Ambu gave FDA a time frame. But the agency was not satisfied with it, so they handed a warning letter to the Danish company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Chinese copycats target promising Ambu product
For abonnenter
Ambu: It’s like moving into the big leagues
For abonnenter
American acquisition leads to European opportunities
For abonnenter
